Vincerebio
3 known investors
Vincere develops therapeutics for age-related diseases such as Parkinson's and kidney disease, using a computational platform that combines human genetics, cellular network models, and in-silico biology to identify drug targets like USP30 for mitochondrial repair. The company is developing small-molecule candidates aimed at human trials and pharma partnerships.